Ceres Pharma
ActiveSummary
The computed 12-month bankruptcy probability of Ceres Pharma is 1.9% (moderate). The 2025 annual accounts show negative equity (-€1.6m) and a net result of -€14.4m. The figures fluctuate too strongly year-on-year for a reliable trend projection. Its solvency ranks better than 9% of 788 sector peers (NACE 10, financial year 2025). The company has been active since 2015 and the Belgian Official Gazette contains no insolvency or warning signals.
Group and network
Holdings and subsidiaries
18 holdings · 23 subsidiaries in the treeHoldings 18
Source for every holding own accounts 2025
- 2PHARMA HOLDINGsubsidiaryEquity €34,480Result -€3,205100%
- Abopharma Bulgaria EOODBGsubsidiaryEquity €300,528Result €18,669100%
- Ceres Pharma Hungary Kft.HUsubsidiaryEquity €4.9mResult €1.0m100%
- Ceres Pharma Italy SRLITsubsidiaryEquity €17.5mResult €2.4m100%
- Ceres Pharma Serbia dooRSsubsidiaryEquity -€335,770Result -€33,953100%
- Ceres Pharma Slovakia SROSKsubsidiaryEquity €62,483Result -€66,831100%
- Ceres PharmaceuticalssubsidiaryEquity €5.3mResult €2.6m100%
- Ceumed EOODBGsubsidiaryEquity €398,026Result €3,197100%
- Ceumed s.r.o.CZCZsubsidiaryEquity €373,644Result €3,790100%
- CREDOPHARsubsidiaryEquity €1.9mResult €51,670100%
Show 8 more holdings
- Dacia PlantROsubsidiaryEquity €8.4mResult €2.1m100%
- GLOBIFER INTLsubsidiaryEquity €9.3mResult €2.2m100%
- MD PharmasubsidiaryEquity €1.8mResult €257,132100%
- Technokom Imoti EOODBGsubsidiaryEquity €157,408Result €27,732100%
- Technokom Rent EOODBGsubsidiaryEquity €239,845Result €103,728100%
- Technokom Trade EOODBGsubsidiaryEquity €2.5mResult €423,881100%
- VESALE PHARMACEUTICAsubsidiaryEquity €3.1mResult -€362,888100%
- Ceres Pharma RomaniaROsubsidiaryEquity €5.4mResult €3.1m99.99%
All subsidiaries, including indirect ones 23
Companies in which this company or one of its subsidiaries holds more than half, or which it consolidates according to the LEI register.
2PHARMA HOLDING 100%1 subsidiary
- 2PHARMA 100%
- Abopharma Bulgaria EOODBG 100%
- Ceres Pharma Hungary Kft.HU 100%
- Ceres Pharma Italy SRLIT 100%
- Ceres Pharma Serbia dooRS 100%
- Ceres Pharma Slovakia SROSK 100%
- Ceres Pharmaceuticals 100%
- Ceumed EOODBG 100%
- Ceumed s.r.o.CZCZ 100%
CREDOPHAR 100%3 subsidiaries
Labophar 100%2 subsidiaries
- b+pharma Belgium 100%
- DGPharma 100%
- Dacia PlantRO 100%
- GLOBIFER INTL 100%
- MD Pharma 100%
- Technokom Imoti EOODBG 100%
- Technokom Rent EOODBG 100%
- Technokom Trade EOODBG 100%
VESALE PHARMACEUTICA 100%1 subsidiary
- Vesale Pharma InternationalLU 100%
- Ceres Pharma RomaniaRO 99.99%
According to the 2025 annual accounts of Ceres Pharma and those of the other companies, the acts in the Belgian Official Gazette and the LEI register. Annual accounts state the shareholders that notified the company under article 7:225 of the Code of Companies and Associations and the parent companies that consolidate it. The register of ultimate beneficial owners (UBO) is not public: who ultimately stands behind a natural person or a foreign parent is not stated here. A company that does not include these statements in its annual accounts, or does not have to, is not listed.
Connections & network
The network starts from this company’s shareholders. What else they own or run appears here as nodes.